NewTimeSpace News,On March 17, Singapore-listed Chasen Holdings announced that its wholly-owned subsidiary CLEE has entered into a share sale and purchase agreement with two vendors to acquire an additional 22.05% equity interest in RPT for S$632,974. Upon completion of the acquisition, Chasen’s shareholding ratio in RPT will rise to 77.05%.
NewTimeSpace News,On March 17, Singapore-listed Samudera Shipping Line announced that its Japanese subsidiary BOS has completed the acquisition and delivery of two container vessels.
NewTimeSpace News,On March 17, Singapore-listed Autagco Ltd. announced that it has entered into a share subscription agreement with Aurico and three independent subscribers, planning to issue up to 3 billion new ordinary shares to raise a total of approximately S$3 million, which will be used to improve the company's financial position, supplement working capital and fuel business expansion.
NewTimeSpace News,On March 17, Singapore-listed Sunrise Shares Holdings announced that it had received a listing and quotation notice from the Singapore Exchange (SGX), in relation to the proposed issuance of 34,482,800 consideration shares. This marks a major progress in its acquisition of the entire equity interest in Fuzhou Tianfujia Industrial Co., Ltd., with all preconditions for the acquisition having been satisfied.
NewTimeSpace News,On March 18, Singapore-listed Marco Polo Marine announced that its indirect subsidiary PKRO has won a 15-year charter contract for emergency towage and salvage services from Taiwan's Marine Port Bureau, with the contract valued at NT$2.948 billion (approximately S$118 million).
NewTimeSpace News,On March 18, Singapore-listed Olam Group announced that its wholly-owned subsidiary ofi, a global provider of natural food and beverage ingredients, has successfully secured its first dual-tranche syndicated loan totalling EUR 1.1 billion, with the proceeds to be used for refinancing ofi’s existing loans and general corporate purposes.
NewTimeSpace: Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (02566.HK) announced that its independently developed JY47 Injection has obtained implicit approval for clinical trials from the National Medical Products Administration (NMPA) of China. The drug is intended for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) with liver fibrosis.
Following a roughly 40% decline in early March, CF PharmTech (02652.HK) closed up 21.39% at HK$27.92 on March 16, 2026, spurred by positive catalysts. On March 13, the IND application for its inhalation dry powder ICF001 (for PAH and PH-ILD) was accepted by the NMPA, potentially filling a domestic void in PH-ILD treatment. While the company has 6 marketed products, its core product CF017 (Budesonide Inhalation) accounts for over 90% of revenue, leaving its risk-resistance structure fragile. The current TTM P/E of 384.57x reflects high market expectations for the innovation pipeline but also carries the risk of a valuation pullback.
NewTimeSpace News,On 16 March, Singapore-listed Stamford Land issued an announcement disclosing that its wholly-owned dormant Australian subsidiary SPS has been the subject of a winding-up petition filed by Parkview with the Supreme Court of New South Wales, Australia. Stamford Land stated that it does not intend to contest the petition, and the matter is not expected to have any material impact on the Group's operations and financial position.
NewTimeSpace News,On 16 March, Singapore-listed Geo Energy announced the completion of its proposed share placement, successfully issuing and placing 35 million new shares at a price of SGD0.425 per share. The placed shares are expected to start trading on the Mainboard of the Singapore Exchange on 18 March.
NewTimeSpace News,On 16 March, Hatten Land, a Singapore-listed company under judicial management, issued an announcement disclosing that it has used a portion of the loan under the facility agreement signed with Skyone to refinance its indebtedness under the previously entered secured facility agreement with Brilliant. Brilliant has executed a deed of discharge and release, formally terminating the relevant secured facility agreement and the assignment of receivables agreement.
NewTimeSpace News,On March 16, Singapore-listed GuocoLand announced that its wholly-owned subsidiary intends to grant an option to purchase a residential unit at River Modern to a connected person of one of the company's directors, with a transaction price of S$2.24 million.
NewTimeSpace News,On March 16, OUE REIT, a Singapore-listed real estate investment trust, announced the completion of its acquisition of a 19.9% stake in Salesforce Tower Sydney, Australia.
NewTimeSpace: SSY Group Limited(02005.HK) announced that its Bumetanide has been approved by the National Medical Products Administration (NMPA) of China for registration as an active pharmaceutical ingredient (API) for use in marketed finished products.Bumetanide is a loop diuretic, mainly indicated for the treatment of edema associated with heart failure, renal dysfunction and hepatic dysfunction.
Affected by the surge in gold prices (breaking $5,100/oz) and the subsequent suppression of consumer demand, Zhou Liu Fu’s (06168.HK) share price continues to decline. As of the close on March 13, 2026, it was quoted at HK$21.28, down nearly 10% from its IPO price, with its market cap shrinking approximately 60% from its November 2025 peak to HK$9.376 billion. In H1 2025, revenue was RMB 3.15 billion and net profit was RMB 415 million. While maintaining double-digit growth, the revenue growth rate has slowed significantly from the 66% seen in 2023. Online channel revenue has surpassed 50% for the first time, becoming the new growth engine.
NewTimeSpace News,According to a Catalist Singapore announcement on March 13, Abundance International announced the establishment of its wholly-owned subsidiary ASC, and ASC simultaneously signed a licence agreement with MTTI of the United States to obtain the exclusive licence for the tumour detection agent CypH-11 in selected Asia-Pacific countries.
